15407 results for "1 mil coins fc 26 Visit Buyfc26coins.com for latest FC 26 coins news..buoc"

in 23.07 milliseconds.

• A98176A

  Whole genome sequencing for single cells for library A98176A 1003 samples; filetype=bam

  Dataset EGAD00001008260

• A98176B

  Whole genome sequencing for single cells for library A98176B 1389 samples; filetype=bam

  Dataset EGAD00001008261

• A98284A

  Whole genome sequencing for single cells for library A98284A 1265 samples; filetype=bam

  Dataset EGAD00001008262

• A98284B

  Whole genome sequencing for single cells for library A98284B 1582 samples; filetype=bam

  Dataset EGAD00001008263

• A98289B

  Whole genome sequencing for single cells for library A98289B 1032 samples; filetype=bam

  Dataset EGAD00001008264

• A98293B

  Whole genome sequencing for single cells for library A98293B 703 samples; filetype=bam

  Dataset EGAD00001008265

• Single Cell Genome Sequence for DLP+ library A118368B

  Single Cell Genome Sequence for triple negative breast cancer patient-derived xenograft SA605 passage 3 on DLP+ library A118368B

  Dataset EGAD00001009432

• Single Cell Genome Sequence for DLP+ library A118425B

  Single Cell Genome Sequence for Immortalized breast epithelium BRCA2+/- Tp53-/- cell line 184-hTert L9 116.66 cell line SA1188 on DLP+ library A118425B

  Dataset EGAD00001009434

• Single Cell Genome Sequence for DLP+ library A96171A

  Single Cell Genome Sequence for triple negative breast cancer patient-derived xenograft SA501 passage 2, patient-derived xenograft SA611 passage 3 on DLP+ library A96171A

  Dataset EGAD00001009458

• Development of CMT Peds Scale for Children with CMT

  Information about how different forms of CMT affect children is not readily available because there are not good methods to measure impairment of children with CMT. The purpose of this project is to develop and test such a method and to then test this scale to ensure that it is an effective measurement of impairment of CMT in children, that the children tolerate it well, that different investigators using this method obtain similar results and that changes over time with the scale allow measurement of progression of CMT in the children. Primary Objective: To develop and test the CMT Peds scale (CMTPedS) in children with CMT in order to refine the scoring for future natural history and therapeutic trials. Secondary Objective: We propose to test the sensitivity of the CMT Peds Scale in a longitudinal study and compare the CMT Peds Scale with the Children's Quality of Life scale CHQ-PF50. 2000 patients <21 years of age with various forms of CMT will be evaluated at baseline and at subsequent annual follow up visits when possible. This first study release makes available data of n=208 study participants.

  Study phs001553